This post was originally published on this site
Abbott Labs announced earnings per share of $1.43 on revenue of $11.26B. Analysts polled by Investing.com anticipated EPS of $1.13 on revenue of $10.31B.
Abbott Labs shares are down 21% from the beginning of the year, still down 22.91% from its 52 week high of $142.60 set on December 27, 2021. They are under-performing the S&P 500 which is down 17.4% from the start of the year.
Abbott Labs shares gained 2.35% in pre-market trade following the report.
Abbott Labs’s report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.55 on revenue of $23.8B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
